Sage Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
02 Apr 2025	Form 3: Quirk Michael C., See Remarks Holds 27,108 shares of Common Stock
01 Nov 2024	Form 3: Shiferman Gregory L., See Remarks Holds 14,967 shares of Common Stock
17 Mar 2023	Form 3: Federer Jessica, Director No securities owned
01 Nov 2022	Form 3: Gault Laura, Chief Medical Officer No securities owned
13 Sep 2021	Form 3: Benecchi Christopher, Chief Commercial Officer No securities owned
11 Jan 2021	Form 3: Biogen Inc., 10% owner and 1 other Holds 6,241,473 shares of Common Stock
05 Oct 2020	Form 3: Greene Barry E, Director No securities owned
24 Jan 2019	Form 3: Barrett Elizabeth, Director No securities owned
24 Jan 2019	Form 3: Golumbeski George, Director No securities owned
08 Nov 2017	Form 3: Nayak Asha, Director No securities owned
25 Apr 2017	Form 3: Cloonan Michael, Chief Business Officer No securities owned
19 Jul 2016	Form 3: Germano Geno J, Director No securities owned
17 Sep 2015	Form 3: Cook Anne Marie, General Counsel Holds 0 shares of Common Stock
11 Sep 2014	Form 3: Cola Michael F, Director No securities owned
17 Jul 2014	Form 3: Anderson Thomas, See Remarks
17 Jul 2014	Form 3: Paul Steven M, Director Holds 793,650 shares of Common Stock
17 Jul 2014	Form 3: Pien Howard H, Director
17 Jul 2014	Form 3: Iguchi Kimi, See Remarks Holds 92,063 shares of Common Stock
17 Jul 2014	Form 3: Robichaud Albert, Chief Scientific Officer Holds 222,222 shares of Common Stock
17 Jul 2014	Form 3: Third Rock Ventures II, L.p., 10% owner and 4 others Holds 476,189 shares of Common Stock

Comments